logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pasquale Lombardi

imperial college london
H指数:19
被引数:1,323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MAP of molecular analyses in real-worlD oncology centers – MAPpaMoNDO: a study of the translational research Young GOIM group

现实世界肿瘤中心分子分析地图——MAPpaMoNDO：青年GOIM组转化研究的研究

Journal of Translational Medicine
IF7.5
2026-08-180
OA
Federica Papaccio; Pasquale Lombardi; Gaia Giannone; Francesca Carlino; Angelica Petrillo; Rosa Falcone; Ina Valeria Zurlo; Alessandro Parisi; Salvatore Corallo; Concetta Sergi; Alessandro Caputo; Francesco Pepe; Vincenzo De Falco; Antonio Febbraro; Roberto Bordonaro; Davide Ciardiello; Alberto Servetto; Paola Parente; Carminia Maria Della Corte
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

不可切除肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗长期生存的影响因素

European Journal of Cancer
IF7.1
2026-04-160
PRE
Pei-Chang Lee; Alessio Cortellini; Bernardo Stefanini; Changhoon Yoo; Hong Jae Chon; Jaekyung Cheon; Masatoshi Kudo; Naoshi Nishida; Bernhard Scheiner; Matthias Pinter; Pasquale Lombardi; Claudia Angela Maria Fulgenzi; Antonio D'Alessio; Leonardo Brunetti; Aria Torkpour; Elena Valenzi; Fionnuala Crowley; Thomas U Marron; Wei-Fan Hsu; Ciro Celsa
Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals

肿瘤学出版中的人工智能：高影响因子期刊的系统综述与政策分析

Frontiers in Oncology
IF3.3
2026-04-010
OAAI
RG Raffaele Giusti; MF Marco Filetti; PL Pasquale Lombardi; FL Francesca Lo Bianco; SS Stefano Sganga; TG Tommaso Giovagnoli; GM Giovanni Maria Iannantuono; AS Andrea Spinazzola; DS Daniele Santini; MM Monica Mariniello; GP Giampiero Porzio; MI Mohsen Ibrahim; GD Gennaro Daniele
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study

使用高级机器学习方法预测阿替利珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的结局：一项回顾性队列研究

The Lancet Digital Health
IF0
2026-02-120
OAAI
Mathew Vithayathil; Giulia Francesca Manfredi; Antonio D’Alessio; Claudia Angela Maria Fulgenzi; Ciro Celsa; Pasquale Lombardi; Aria Torkpour; Bernardo Stefanini; Peter R Galle; Naoshi Nishida; Bernhard Scheiner; Fionnuala Crowley; Linda Wu; Celina Ang; Thomas U Marron; Wei-Fan Hsu; Chun-Yen Lin; Ryan Po-Ting Lin; Susanna V Ulahannan; Haripriya Andanamala
Lenvatinib versus sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: the LEVIATHAN Study

伦伐替尼对比索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌的二线治疗：LEVIATHAN 研究

JHEP Reports
IF7.5
2025-09-230
OAAI
Pasquale Lombardi; Jung Sun Kim; Giulia F. Manfredi; Ciro Celsa; Claudia A.M. Fulgenzi; Antonio D’Alessio; Bernardo Stefanini; Niraj C. Doshi; Emily Warmington; Thomas U. Marron; Matthias Pinter; Bernhard Scheiner; Beodeul Kang; Ho Yeong Lim; Wei-Fan Hsu; Brooke Wietharn; Marianna Silletta; Alessandro Parisi; Chun-Yen Lin; Andrea Dalbeni; Gianluca Masi; Martin Schönlein; Johann von Felden; Fabio Piscaglia; Peter R. Galle; Masatoshi Kudo; Tiziana Pressiani; Lorenza Rimassa; Mario Pirisi; Giuseppe Cabibbo; Hong Jae Chon; David J. Pinato
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

癌症临床试验中与FDA药物审批相关的患者入组标准及基线特征（2009–2023）

European Journal of Cancer
IF7.1
2025-06-260
OA
Giovanni Maria Iannantuono; Charalampos S. Floudas; Marco Filetti; Tommaso Giovagnoli; Stefano Sganga; Antonio Vitale; Elias Chandran; Pasquale Lombardi; Roberto Rosenfeld; Elena Giudice; Elisabetta Xue; Elvira Rapisarda; Paola Troisi; Andrea B. Apolo; Fatima Karzai; Emilio Bria; James L. Gulley; Gennaro Daniele
An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study
EUROPEAN JOURNAL OF CANCER
IF7.1
2025-01-010
PRE
Trapani, Dario; Nidhamalddin, Sara J.; Gandini, Sara; Filetti, Marco; Altuna, Sara C.; Schianca, Ambra Carnevale; Petrillo, Angelica; Murthy, Shilpa M.; Girardi, Fabio; Bezuidenhout, Jacques B.; El Bairi, Khalid; Lombardi, Pasquale; Khan, Shah Z.; Lengyel, Csongor G.; Seeber, Andreas; Hussain, Sadaqat; Seid, Fahmi U.; Elfaham, Essam; Odhiambo, Andrew O.; Coskun, Yakup; Baker, Habeeb S.; Chowdhury, Arman R.; Genazzani, Armando; Daniele, Gennaro; Porzio, Giampiero; Curigliano, Giuseppe; Giusti, Raffaele
TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)

TP53截短突变和错义突变与晚期非小细胞肺癌（NSCLC）患者对检查点阻断疗法的差异化响应相关联。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Citarella, F.; Russano, M.; Fiorenti, M.; La Cava, G.; Pizzutilo, E. G.; Martinelli, F.; Pierri, S.; Russo, A.; Muscolino, P.; Sapuppo, E.; Marinello, A.; Aldea, M.; Besse, B.; Filetti, M.; Lombardi, P.; Vitale, A.; Buzzacchino, F.; Cristofani, L.; Lugini, A.; Cortellini, A.
Lenvatinib versus sorafenib as a second-line option in patients with unresectable hepatocellular carcinoma previously treated with atezolizumab plus bevacizumab: An observational study

仑伐替尼与索拉非尼作为接受过阿替利珠单抗联合贝伐珠单抗治疗的不切除肝细胞癌患者的二线治疗选择：一项观察性研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lombardi, P.; Manfredi, G. F.; Celsa, C.; Stefanini, B.; Marron, T.; Saeed, A.; Pinter, M.; Ulahannan, S.; Piscaglia, F.; Lin, C-Y.; Dalbeni, A.; Masi, G.; Schoenlein, M.; Galle, P. R.; Kudo, M.; Rimassa, L.; Chon, H.; Pirisi, M.; Pinato, D. J.
Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023)

临床 trials 中 performance status 限制与 US food and drug administration (FDA) 药物审批的关系：一项跨越十年（2014-2023）的横断面研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Iannantuono, G. M.; Filetti, M.; Giudice, E.; Sganga, S.; Chandran, E. B. A.; Xue, E.; Lombardi, P.; Rosenfeld, R.; Rapisarda, E.; Ferri, L.; De Rubeis, G.; Lorusso, D.; Floudas, C.; Gulley, J. L.; Apolo, A. B.; Lee, J-M.; Karzai, F.; Altamura, V.; Scambia, G.; Daniele, G.
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study

2017年和2021发表的肿瘤学随机临床试验中控制臂的充分性分析: 一项荟萃研究

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-08-019
PRE
Rossi, Alessandro; Aimar, Giacomo; Audisio, Marco; Bungaro, Maristella; Caglio, Andrea; Di Liello, Raimondo; Gamba, Teresa; Gargiulo, Piera; Ghisoni, Eleonora; Lombardi, Pasquale; Marandino, Laura; Mariniello, Annapaola; Paratore, Chiara; Reale, Maria Lucia; Trastu, Federica; Tuninetti, Valentina; Turco, Fabio; Fabi, Alessandra; Perrone, Francesco; Di Maio, Massimo
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis

止吐方案治疗高度致吐性化疗引起的恶心和呕吐的有效性和安全性: 系统评价和网络荟萃分析

CANCER TREATMENT REVIEWS
IF10.5
2023-04-0111
PRE
Filetti, Marco; Lombardi, Pasquale; Giusti, Raffaele; Falcone, Rosa; Scotte, Florian; Giannarelli, Diana; Carcagni, Antonella; Altamura, Valeria; Scambia, Giovanni; Daniele, Gennaro

研究方向

暂未获取到该数据
M
Marco Filetti
H 指数:28论文数:257被引数:3,553
G
Gennaro Daniele
H 指数:36论文数:182被引数:4,152
F
Francesco Leone
H 指数:39论文数:278被引数:6,291
M
Massimo Aglietta
H 指数:76论文数:776被引数:2.4万
M
Massimo Di Maïo
H 指数:66论文数:768被引数:1.8万
S
Susana Roselló
H 指数:37论文数:232被引数:6,144
A
Andrés Cervantes
H 指数:99论文数:1,158被引数:6.1万
G
Giampiero Porzio
H 指数:43论文数:233被引数:5,744
G
Giacomo Aimar
H 指数:8论文数:22被引数:176
F
Francesco Perrone
H 指数:53论文数:374被引数:1.1万